Tina Marriott - 15 May 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
President and COO
Signature
/s/Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
15 May 2024
Net transactions value
-$100,080
Form type
4
Filing time
17 May 2024, 19:12:21 UTC
Previous filing
29 Apr 2024
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Tax liability $100,080 -9,998 -1.8% $10.01 533,233 15 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RXRX Stock Option (Right to Buy) 485,000 15 May 2024 Class A Common Stock 0 $1.06 Direct F2
holding RXRX Stock Option (Right to Buy) 434,122 15 May 2024 Class A Common Stock 0 $8.55 Direct F3
holding RXRX Stock Option (Right to Buy) 159,226 15 May 2024 Class A Common Stock 0 $11.40 Direct F4
holding RXRX Stock Option (Right to Buy) 4,784 15 May 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 150,000 15 May 2024 Class A Common Stock 0 $2.48 Direct F5
holding RXRX Stock Option (Right to Buy) 447,917 15 May 2024 Class A Common Stock 0 $10.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F2 Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
F3 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5 One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.
F6 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.